A 60-year-old man with long-term exposure to toluene presented with both myelofibrosis and focal segmental glomerulosclerosis. There was also evidence of other toluene-related complications to support the diagnosis of toluene toxicity. The toxic effects of toluene, particularly kidney disorders and haematotoxicity, suggest a relationship between toluene, myelofibrosis and focal segmental glomerulosclerosis.
Get full access to this article
View all access options for this article.
References
1.
Taher SM, Anderson RJ, McCartney R., Popovtzer MM & Schrier RWRenal tubular acidosis associated with toluene 'sniffing'. New England Journal of Medicine1974; 209: 765-8.
2.
Reisin E., Teicher A., Jaffe R. & Eliahou HEMyoglobinuria and renal failure in toluene poisoning. British Journal of Industrial Medicine1975; 32: 163-8.
3.
Hayden JW, Peterson RG & Bruckner JVToxicology of toluene (methylbenzene): review of current literature. ClinicalToxicology1977; 11: 549-59.
4.
FischmanChM & Oster JR. Toxic effects of toluene. A new cause of high anion gap metabolic acidosis. Journal of theAmerican Medical Association1979; 241: 1713-5.
5.
Cohr K-H. & Stokholm J. Toluene .A toxicologic review. Scandinavian Journal of Work Environment and Health1979; 5: 71-90.
6.
O'Brien ETYeoman WB&Hobby Jae.Hepatorenal damage from toluene in a 'glue sniffer'. British Medical Journal1971; ii: 29-30.
7.
Ramos Castro J., Salvador Ballaz B., Manrique Larralde A., Maravi Poma E., Madurga Perez P. & Sanchez Nicolay I., Intoxicación aguda por tolueno. Medicina Intensiva1987; 11: 30-1.
8.
Girard R., Tolot F. & Bourret J.Hydrocarbures benzéniques et hémopathies graves. Archives des Maladies Professionnelles, de Médecine du Travail et de Sécurité (Paris) 1970; 31: 625-36.
9.
Askoy M., Dincol K., Erdem S. & Dincol G.Acute leukemia due to chronic exposure to benzene. American Journal of Medicine1972; 52: 160-6.
10.
Hu H.Benzene-associated myelofibrosis. Annals of Internal Medicine1987; 106: 171-2.
11.
Celada A.Mielofibrosis crónica idiopatica. Estudio de treinta y seis pacientes y revisión de la literatura. Sangre1983; 28: 401-20.
12.
Sultan C., Sigaux F., Imbert M. & Reyes F.Acute myelodysplasia with myelofibrosis: a report of eight cases. British Journal of Haematology1981; 49: 11-16.
13.
Bergsman & KLVan Slyck EJAcute myelofibrosis. An accelerated variant of agnogenic myeloid mataplasia. Annals of Internal Medicine1971; 74: 232-5.
14.
Manoharan A. , Smart RC & Pitney WRPrognostic factors in myelofibrosis. Pathology1982; 14: 455-61.
15.
Varki A., Lottenberg R., Griffith R. & Reinhard E.The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival. Medicine1983; 62: 353-71.
16.
Ward HP & Block MHThe natural history of agnogenic myeloid mataplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine1971; 50: 357-420.
17.
Jacobson RJ , Salo A. & Fialkow PJAgnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis . Blood1978; 51: 189-94.
18.
Weinberg SG , Lubin A., Wiener SN, Deoras MP, Ghose MK & Kopelman RCMyelofibrosis and renal osteodystrophy. American Journal of Medicine1977; 63: 755-64.
Jenis EH, Teichman S., Briggs WA, et al. Focal segmental glomerulosclerosis. American Journal of Medicine1974; 57: 695-705.
21.
Ravnskov U. , Forsberg B. & Skerfving S.Glomerulonephritis and exposure to organic solvents. A case-control study. Acta Medica Scandinavica1979; 205: 575-9.
22.
Ravnskov U. , Lundström S. & Nordén A.Hydrocarbon exposure and glomerulonephritis: evidence from patients' occupations. Lancet1983; ii: 1214-6.
23.
Glassock RJ, Adler SG, Ward HJ & Cohen AHPrimary glomerular diseases. In The Kidney, volume i, eds BM Brenner & FC Rector jr, pp. 929-1013. Philadelphia: WB Saunders, 1986.
24.
Velosa JA, Donadio JV jr & Holley KEFocal sclerosing glomerulonephropathy. A clinicopathologic study. Mayo Clinic Proceedings1975; 50: 121-33.
25.
Bell GM, Gordon Ach, Lee P., et al. Proliferative glomerulonephritis and exposure to organic solvents . Nephron1985; 40: 161-5.
26.
Von Schéele C., Althoff P., Kempi V. & Schelin U.Nephrotic syndrome due to subacute glomerulonephritis— association with hydrocarbon exposure? . Acta Medica Scandinavica1976; 200: 427-9.
27.
Zimmerman SW , Groehler K. & Beirne GJHydrocarbon exposure and chronic glomerulonephritis . Lancet1975 ; ii: 199-201.
Cagnoli L., Casanova S., Pasquali S., Donini U. & Zucchelli P.Relation between hydrocarbon exposure and the nephrotic syndrome. British Medical Journal1980; 280: 1068-9.
30.
Harman JWChronic glomerulonephritis and the nephrotic syndrome induced in rats with N,N'-diacetyl-benzidine. Journal of Pathology1971; 104: 119-28.
31.
Finn R., Fennerty AG & Ahmad R.Hydrocarbon exposure and glomerulonephritis. Clinical Nephrology1980; 14: 173-5.
32.
Churchill DN, Fine A. & Gault MHAssociation between hydrocarbon exposure and glomerulonephritis. An
33.
appraisal of the evidence. Nephron1983; 33: 169-72.
34.
Lange A., Smolik R., Zatonski W. & Glazman H.Leukocyte agglutinins in workers exposed to benzene, toluene and xylene . Internationales Archiv für Arbeits-Medizin1973; 31: 45.
